Insider Transactions in Q1 2025 at Apellis Pharmaceuticals, Inc. (APLS)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Jan 06
2025
|
Caroline Baumal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,816
-4.82%
|
$92,928
$33.81 P/Share
|
Jan 01
2025
|
Stephanie Monaghan O'Brien Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+26.14%
|
-
|
Jan 01
2025
|
Alec Machiels Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+1.64%
|
-
|
Jan 01
2025
|
A. Sinclair Dunlop Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+3.81%
|
-
|
Jan 01
2025
|
Paul R. Fonteyne Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+21.63%
|
-
|
Jan 01
2025
|
Gerald Chan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,267
+26.14%
|
-
|